EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID

Yukichika Yamamoto iD, Yuki Otsuka iD, Kazuki Tokumasu iD, Naruhiko Sunada, Yasuhiro Nakano iD, Hiroyuki Honda iD, Yasue Sakurada, Toru Hasegawa, Hideharu Hagiya iD, Fumio Otsuka iD

Journal of Clinical Medicine · 18.07.2023 · 12 (14) · 4737

DOI: 10.3390/jcm12144737 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.07.2023. Verfasst von Yukichika Yamamoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI, Okayama Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The most common symptom of post-acute coronavirus disease 2019 (COVID-19) is fatigue, and it potentially leads to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, a specific prognosticator is lacking. We aimed to elucidate the clinical characteristics of patients who developed ME/CFS after COVID-19.

Methods

In this retrospective observational study, patients who visited Okayama University Hospital for long COVID between February 2021 and March 2022 were investigated.

Results

Of the 234 patients, 139 (59.4%) had fatigue symptoms. Fifty patients with fatigue symptoms (21.4%) met the criteria for ME/CFS (ME/CFS group), while the other 89 patients did not (non-ME/CFS group); 95 patients had no fatigue complaints (no-fatigue group). Although the patients’ backgrounds were not significantly different between the three groups, the ME/CFS group presented the highest scores on the self-rating symptom scales, including the Fatigue Assessment Scale (FAS), EuroQol, and the Self-Rating Depression Scale (SDS). Furthermore, serum ferritin levels, which were correlated with FAS and SDS scores, were significantly higher in the ME/CFS group (193.0 ng/mL, interquartile range (IQR): 58.8–353.8) than in the non-ME/CFS group (98.2 ng/mL, 40.4–251.5) and no-fatigue group (86.7 ng/mL, 37.5–209.0), and a high serum ferritin level was prominent in female patients. Endocrine workup further showed that the ME/CFS group had higher thyrotropin levels but lower growth hormone levels in serum and that insulin-like growth factor-I levels were inversely correlated with ferritin levels (R = −0.328, p < 0.05).

Conclusions

Serum ferritin level is a possible predictor of the development of ME/CFS related to long COVID, especially in female patients.

Schlagwörter

Stichwörter der Autor:innen

COVID-19ferritininsulin-like growth factor-I (IGF-I)long COVIDmyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Autor:innen und Institutionen

  • Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

ORCID-Profile: Yukichika Yamamoto, Yuki Otsuka, Kazuki Tokumasu, Yasuhiro Nakano, Hiroyuki Honda, Hideharu Hagiya, Fumio Otsuka

Förderung

  • Japan Society for the Promotion of Science
  • JSPS KAKENHI
  • Okayama Medical Foundation
  • Japanese Society of Hospital General Medicine
  • Ryobi Teien Memory Foundation (2022)

Zitieren

APA

Yamamoto, Y., Otsuka, Y., Tokumasu, K., Sunada, N., Nakano, Y., Honda, H., Sakurada, Y., Hasegawa, T., Hagiya, H., & Otsuka, F. (2023). Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID. Journal of Clinical Medicine, 12(14), 4737. https://doi.org/10.3390/jcm12144737

Vancouver

Yamamoto Y, Otsuka Y, Tokumasu K, Sunada N, Nakano Y, Honda H, et al. Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID. Journal of Clinical Medicine. 2023;12(14):4737. doi:10.3390/jcm12144737

BibTeX
@article{Yamamoto2023,
  author = {Yamamoto, Yukichika and Otsuka, Yuki and Tokumasu, Kazuki and Sunada, Naruhiko and Nakano, Yasuhiro and Honda, Hiroyuki and Sakurada, Yasue and Hasegawa, Toru and Hagiya, Hideharu and Otsuka, Fumio},
  title = {Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {14},
  pages = {4737},
  doi = {10.3390/jcm12144737}
}
Kostenlos starten →